Monday, 28 May 2018

Drug Safety

Datesort ascending Type Title Save
13 Oct 2017 Social RT @RonanTKavanagh: Autoimmune thyroid disease as a possible S/E of Anti TNF agents. Didn’t know that. Til today. https://t.co/y9VO3HkedA #…
13 Oct 2017 Social Anfibrotic effx of antiviral Nelfinavir shown to decr TGF-β1-mediated pulm fibrosis & myofibroblast differentiation https://t.co/dSMmMuzYLh
10 Oct 2017 Social 31465 on ULT, allopurinol assoc w/ 39% lower risk renal dz (HR 0.61 vs febuxostat). Higher doses = more protection https://t.co/EsJuyBt3Cy
10 Oct 2017 Social 21 w/ Henoch Schonlein Purpura Rx w/ RTX: 20/21 achieved remission; w/ improved Proteinuria, BVAS, CRP; 35% relapsed https://t.co/NR6c9E1d0s
09 Oct 2017 Social Jan 1st CIGNA will stop covering Oxycontin - is this improved safety or another way to max $$$ &reduce company risk? https://t.co/2TLnnsK80X
09 Oct 2017 Social HCQ decreases CV events, DM 41% & benefits metabolic profile in RA- HCQ useful add on w/ other DMARDs @DrPetryna https://t.co/wnLEqcDkuN
09 Oct 2017 Social Annual costs assoc w/ adverse drug events in US rose from $76.6 billion 1995 to >$177.4 bill 2000; hosp 70% of total https://t.co/WPgW0AlyKK
08 Oct 2017 Social RheumNOw Wk in Review is Up! Tof lymphoma risk, early Dx of RA, Preg & biologics, 2016 top 5 Rheumatology drugs. https://t.co/UypuxfiFyu
08 Oct 2017 Social RT @DrPetryna: Report fromHCQ decreases CV events&benefits metabolic profile in RA- HCQ useful add on w/other DMARDs @RheumNow https://t.…
06 Oct 2017 Social 2016 US Top selling drugs: Humira $13.6 billion, Enbrel $7.4 billion, Remicade $5.3 billion, Lyrica $4.4B,RTX $3.9B https://t.co/FZM2Vow44n
05 Oct 2017 Social RheumNow has the Rules for Stopping Biologics or DMARDs in the setting of infection, esp nonserious infections. https://t.co/3a9lMCLcR1
05 Oct 2017 Social Tramadol dosing: max is 400 mg/d. For those >75 yrs, the max is 300 mg/f; those w/ CKD (<30 mL/min) 200 mg/d https://t.co/3mbn9xiHVi
03 Oct 2017 Social `07 JIA pts followed for 3 yrs on Biologics- 25% (35) had Serious/Opportunistic infx. range 10.6-14.8/100py https://t.co/8kad5PmLKR
03 Oct 2017 Social In 19 RCTs, 6194 RA pts received tofacitinib for 19406 pt-Yrs & 19 developed lymphoma (SIR 2.62) or 1:1000 PY risk https://t.co/UuWEQmGEGB
02 Oct 2017 Social Systematic review shows Colchicine during pregnancy doesn't increase malformations or miscarriage in FMF women. https://t.co/FPaaweU78H
02 Oct 2017 Social RA RCT Inclusion of FM or Depression pts or pts on SSRI had 10% less ACR20 & 1/2 LDAS responses, more W/D & AE https://t.co/TaXhrLsxPU
01 Oct 2017 Social You can Search the FDA FAERS (MedWatch) for Drug specific Adverse events - Cool! https://t.co/FgMyj2OfZx
01 Oct 2017 Social RheumNow Wk in Review is up! Podcast https://t.co/wn1XB7TY43 or Watch it!! https://t.co/h6fppDdYcH
29 Sep 2017 Social RheumNow Wk in Review is up! Podcast https://t.co/j3K7fjbXOG or Watch it!! https://t.co/ymFBPEHuY4
28 Sep 2017 News Safety of Long-Term PPI Use